Newswise — This week's TIME cover story tackles the topic of gene editing, highlighting the potential of a new technology called CRISPR to prevent disease by permanently altering human DNA.

The story was prompted by a U.K.’s approval of a scientist’s request to use CRISPR to alter the genetic code of human embryos. Also this week, the U.S., National Institutes of Health approved a proposal to use CRISPR to augment cancer therapies. Clinical trials could start by the end of the year.

Dana Carroll, Ph.D., distinguished professor of biochemistry at the University of Utah, is a pioneer in gene editing. He developed techniques that presaged CRISPR and is a sought after expert in the field.

Carroll is available for interview. He can explain:• The specifics of gene editing technologies including CRISPR and how they work• How gene editing is being developed to improve human health, and in agriculture to improve our food supply• Barriers that must be overcome before CRISPR can be used safely

Contact Julie Kiefer at 801-597-4258, [email protected]

MEDIA CONTACT
Register for reporter access to contact details